sterlingschrute
New Member
Reta Use and Related Glucagon Agonism
7 weeks into Reta, I haven't seen any verifiable RHR increase (tracking daily), but I'm also just getting to 4mg now. From my understanding (due diligence and thanks to posts and discussion by @Ghoul), the glucagon agonism really starts to make itself known at the 4mg point, and quickly upticks as 6mg, 8mg, and higher doses are reached.
I am going to make blanket, overly generalized statements here, but hear me out.
GLP users largely fall into two camps -- 1) those that are using the GLP as the sole compound in their "research", and 2) those that are using GLP as a supplement / "side piece" to other compounds in their peptide/AAS cycle.
- Group 1 is probably more likely to hit the higher 4,6,8, etc. doses as this is the sole compound fueling their weight loss journey. Accordingly, this group would realize more of the glucagon agonism benefits that Reta can yield.
- Group 2, on the other hand, is probably less likely to hit the higher doses (at least on a lean bulk, those on a hard cut may hit the 4+mg levels). Accordingly, this group would largely (not completely) miss out on the glucagon agonism.
Group 2 often takes the strategy of microdosing Reta, staying below 2-3mg. The logic is to stay on the minimum effective dose possible to avoid sides or the ability to eat while on an AAS cycle, since your growth is largely dependent on how much food you can shovel down.
EC(A). Huh?
pubmed.ncbi.nlm.nih.gov
pmc.ncbi.nlm.nih.gov
ECA stacks have been popular for at least 30 years for the potential (documented success) to promote thermogenesis without getting into the real, harsher compounds (clen, dnp, etc.). Ephedrine is a stimulant that may increase metabolism, suppress appetite, and promote fat burning (thermogenesis). Caffeine is meant to amplify the effects of ephedrine, potentially increasing energy expenditure and alertness. Aspirin is often seen as optional (protect yo gut playa), but is thought to potentially enhance the delivery of ephedrine and caffeine and help maintain the stimulant effects.
How do we get Group 2 to realize more of the glucagon agonist properties of "high-dose Reta" (4+mg) while staying at micro dose levels (sub-4mg)? My Hypothesis.
If Group 2 utilizes micro-dose levels of Reta (sub-4mg) but adds ephedrine (sulfate, OTC Bronkaid Max) and caffeine into the picture, they may be able to replicate the metabolism/fat burning effects that Group 1 experiences on higher doses (4+mg) of Reta alone.
Any thoughts? Do you think the two "stacks" would synergize, or overload the cardiovascular system and lead to adverse events? Has anyone tried this combo, that would be willing to share their anecdotal experience?
7 weeks into Reta, I haven't seen any verifiable RHR increase (tracking daily), but I'm also just getting to 4mg now. From my understanding (due diligence and thanks to posts and discussion by @Ghoul), the glucagon agonism really starts to make itself known at the 4mg point, and quickly upticks as 6mg, 8mg, and higher doses are reached.
I am going to make blanket, overly generalized statements here, but hear me out.
GLP users largely fall into two camps -- 1) those that are using the GLP as the sole compound in their "research", and 2) those that are using GLP as a supplement / "side piece" to other compounds in their peptide/AAS cycle.
- Group 1 is probably more likely to hit the higher 4,6,8, etc. doses as this is the sole compound fueling their weight loss journey. Accordingly, this group would realize more of the glucagon agonism benefits that Reta can yield.
- Group 2, on the other hand, is probably less likely to hit the higher doses (at least on a lean bulk, those on a hard cut may hit the 4+mg levels). Accordingly, this group would largely (not completely) miss out on the glucagon agonism.
Group 2 often takes the strategy of microdosing Reta, staying below 2-3mg. The logic is to stay on the minimum effective dose possible to avoid sides or the ability to eat while on an AAS cycle, since your growth is largely dependent on how much food you can shovel down.
EC(A). Huh?
Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity - PubMed
The safety and efficacy of a mixture of ephedrine (75-150mg), caffeine (150mg) and aspirin (330mg), in divided premeal doses, were investigated in 24 obese humans (mean BMI 37.0) in a randomized double blind placebo-controlled trial. Energy intake was not restricted. Overall weight loss over 8...
Use of a Prescribed Ephedrine/Caffeine Combination and the Risk of Serious Cardiovascular Events: A Registry-based Case-Crossover Study - PMC
Ephedrine and herbal ephedra preparations have been shown to induce a small-to-moderate weight loss. Owing to reports on serious cardiovascular events, they were banned from the US market in 2004. There have been no large controlled studies on the ...
ECA stacks have been popular for at least 30 years for the potential (documented success) to promote thermogenesis without getting into the real, harsher compounds (clen, dnp, etc.). Ephedrine is a stimulant that may increase metabolism, suppress appetite, and promote fat burning (thermogenesis). Caffeine is meant to amplify the effects of ephedrine, potentially increasing energy expenditure and alertness. Aspirin is often seen as optional (protect yo gut playa), but is thought to potentially enhance the delivery of ephedrine and caffeine and help maintain the stimulant effects.
How do we get Group 2 to realize more of the glucagon agonist properties of "high-dose Reta" (4+mg) while staying at micro dose levels (sub-4mg)? My Hypothesis.
If Group 2 utilizes micro-dose levels of Reta (sub-4mg) but adds ephedrine (sulfate, OTC Bronkaid Max) and caffeine into the picture, they may be able to replicate the metabolism/fat burning effects that Group 1 experiences on higher doses (4+mg) of Reta alone.
Any thoughts? Do you think the two "stacks" would synergize, or overload the cardiovascular system and lead to adverse events? Has anyone tried this combo, that would be willing to share their anecdotal experience?
Last edited:

